Evidence map›Paper›PMID 31649970›Full record

ArticleJAAD case reports2019

Complete clinical response to intralesional talimogene laherparepvec injection in a patient with recurrent, regionally advanced Merkel cell carcinoma.

Michael H K Nguyen, Stanley P Leong, Roy Abendroth, Mohammed Kashani-Sabet, Kevin B Kim

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Talimogene Laherparepvec in Non-Melanoma Cancers.The Journal of clinical and aesthetic dermatology · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael H K NguyenCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Stanley P LeongCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Roy AbendrothCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Mohammed Kashani-SabetCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Kevin B KimCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
California Pacific Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CT, computed tomography scanintralesionalMCC, Merkel cell carcinomaMerkel cell carcinomaoncolyticPET, positron emission tomographytalimogene laherparepvecT-VEC, talimogene laherparepvec

Identifiers

PMID31649970
PMCPMC6804468
OpenAlexW2975395798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.